ClinicalTrials.Veeva

Menu

A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status and phase

Completed
Early Phase 1

Conditions

Healthy Adult Volunteers

Treatments

Biological: Activated Charcoal and Apple Juice
Biological: Activated charcoal and Tap Water

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04204772
UL1TR002494 (U.S. NIH Grant/Contract)
2019LS014
HM2019-12 (Other Identifier)

Details and patient eligibility

About

This is a pilot study designed to test feasibility, tolerability, and safety of medical grade oral Activated Charcoal (AC) in 12 healthy volunteers. To determine the two most palatable and tolerable AC combinations. There will be a total of 4 combinations (2 AC doses and 2 solutions) in stage 1. Each participant will drink an assigned combination every day for 3 consecutive days (Monday, Tuesday, Wednesday, "M/T/W") and switch to a different assigned combination M/T/W the following week. AC solution assignments will be defined before the study using a balanced incomplete block design. Each subject will rate their experience using a 5-point scale every day for the 12 days they are on study.

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥18 years
  • No use of prescription medications, including oral birth control, currently or in the last 30 days
  • Sexually active women must be using an effective form of contraception. Note that subjects who are on oral contraception should use an additional form of contraception such as barrier methods, as AC may interfere with the efficacy of oral contraceptive
  • Voluntary written consent signed before performance of any study-related procedure

Exclusion criteria

  • At risk of GI hemorrhage or perforation due to underlying pathology, recent surgery, or medical conditions that could be adversely affected by the administration of AC
  • Planning to have an endoscopic procedure
  • Known hypersensitivity to AC
  • Non-English speakers

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

12 participants in 4 patient groups

Solution A Dose 1, Then Solution B Dose 2
Experimental group
Description:
Participants initially assigned to Solution A Dose 1 will complete the three day course (days 1-3) and switch to the Solution B Dose 2 arm to complete the three day course (days 8-10). The dose level for Solution A Dose 1 is 12 grams of medical grade oral AC mixed with 4 ounces of tap water. Participants will report on a daily basis and consume the assigned combination of oral AC.
Treatment:
Biological: Activated charcoal and Tap Water
Solution A Dose 2, Then Solution B Dose 1
Experimental group
Description:
Participants initially assigned to Solution A Dose 2 will complete the three day course (days 1-3) and switch to the Solution B Dose 1 arm to complete the three day course (days 8-10). The dose level for Solution A Dose 2 is 25 grams of medical grade oral AC mixed with 4 ounces of tap water. Participants will report on a daily basis and consume the assigned combination of oral AC.
Treatment:
Biological: Activated charcoal and Tap Water
Solution B Dose 1, Then Solution A Dose 2
Experimental group
Description:
Participants initially assigned to Solution B Dose 1 will complete the three day course (days 1-3) and switch to the Solution A Dose 2 arm to complete the three day course (days 8-10). The dose level for Solution B Dose 1 is 12 grams of medical grade oral AC mixed with 4 ounces of apple juice. Participants will report on a daily basis and consume the assigned combination of oral AC.
Treatment:
Biological: Activated Charcoal and Apple Juice
Solution B Dose 2, Then Solution A Dose 1
Experimental group
Description:
Participants initially assigned to Solution B Dose 2 will complete the three day course (days 1-3) and switch to the Solution A Dose 1 arm to complete the three day course (days 8-10). The dose level for Solution B Dose 2 is 25 grams of medical grade oral AC mixed with 4 ounces of apple juice. Participants will report on a daily basis and consume the assigned combination of oral AC.
Treatment:
Biological: Activated Charcoal and Apple Juice

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems